Direct Comparison of Insulin Lispro and Aspart Shows Small Differences in Plasma Insulin Profiles After Subcutaneous Injection in Type 1 Diabetes
Open Access
- 1 June 2001
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 24 (6) , 1120-1121
- https://doi.org/10.2337/diacare.24.6.1120
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use.Diabetes, 2000
- Comparative pharmacokinetics and pharmacodynamics of the novel rapid-acting insulin analogue, insulin aspart, in healthy volunteers.European Journal of Clinical Pharmacology, 1999
- The postprandial state and risk of cardiovascular diseaseDiabetic Medicine, 1998
- Action Profile of the Rapid Acting Insulin Analogue: Human Insulin B28AspDiabetic Medicine, 1993
- Comparison of Subcutaneous Soluble Human Insulin and Insulin Analogues (AspB9, GluB27; AspB10; AspB28) on Meal-Related Plasma Glucose Excursions in Type I Diabetic SubjectsDiabetes Care, 1991
- Lack of growth hormone effect on insulin-associated suppression of insulinlike growth factor binding protein 1 in humansDiabetes, 1990